Tag: Rival

Wegovy Maker Novo Nordisk Pumps $6 Billion To Boost Production As Obesity Drug Rival Zepbound Is Approved

Topline Danish pharma giant Novo Nordisk on Friday announced plans to spend $6 billion to boost manufacturing capacity, amid booming

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.